yingweiwo

Monoethylglycinexylidide

Alias: L 86 L-86 L86Monoethylglycinexylidide Ethylglycylxylidide BRN 2417108
Cat No.:V6412 Purity: ≥98%
Monoethylglycinexylidide is a metabolite of lidocaine, which is oxidatively metabolized by cytochrome P-450 enzymes in the liver.
Monoethylglycinexylidide
Monoethylglycinexylidide Chemical Structure CAS No.: 7728-40-7
Product category: New1
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
50mg
100mg
Other Sizes

Other Forms of Monoethylglycinexylidide:

  • Monoethylglycinexylidide hydrochloride (MEGX hydrochloride; Norlidocaine hydrochloride)
  • Monoethylglycinexylidide-d6
  • Monoethylglycinexylidide-d6 HCl
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
Monoethylglycinexylidide is a metabolite of lidocaine, which is oxidatively metabolized by cytochrome P-450 enzymes in the liver.
Monoethylglycinexylidide (CAS 7728-40-7), also known as MEGX or ethylglycylxylidide, is an active metabolite of lidocaine. The molecular formula is C12H18N2O with a molecular weight of 206.28 g/mol. Monoethylglycinexylidide is a metabolite of lidocaine that is formed by oxidative N-deethylation of lignocaine by liver cytochrome P-450 enzymes. The compound is used as a research tool to study lidocaine metabolism and as a marker of liver function. MEGX formation from lidocaine is used as a test of liver function, particularly in the context of liver transplantation and hepatic drug metabolism.
Biological Activity I Assay Protocols (From Reference)
Targets
The primary target of Monoethylglycinexylidide is not a specific receptor, as the compound is a metabolite rather than a therapeutic agent. The compound is formed from lidocaine by oxidative N-deethylation catalyzed by cytochrome P-450 enzymes, primarily CYP3A4 and CYP1A2, in the liver. MEGX itself has some pharmacological activity, including local anesthetic effects similar to lidocaine, although it is less potent than the parent compound. The compound's primary use is as a marker of liver function, as the rate of MEGX formation from lidocaine reflects hepatic metabolic capacity. MEGX may also interact with sodium channels, similar to lidocaine, but with lower affinity.
ln Vitro
In vitro studies on Monoethylglycinexylidide are focused on its role as a metabolite of lidocaine and its use as a marker of liver function. The compound is formed from lidocaine by oxidative N-deethylation in liver microsomes. In vitro metabolism studies using human liver microsomes or recombinant CYP enzymes demonstrate that MEGX formation is primarily catalyzed by CYP3A4 and CYP1A2. The compound can also be used as a substrate in enzyme assays to measure CYP450 activity. No specific biological activity data, such as IC50 or EC50 values, have been reported for MEGX as a pharmacological agent. The compound's local anesthetic activity is significantly less than that of lidocaine.In cell-based assays, Monoethylglycinexylidide could be used to study the metabolism of lidocaine or the effects of MEGX on cellular function. Hepatocytes (primary human hepatocytes or HepG2 cells) are cultured in appropriate medium and treated with lidocaine (0.1-100 µM) for 1-24 hours. MEGX formation in culture supernatants is measured by HPLC or LC-MS/MS. The effects of MEGX on cell viability, sodium channel function, or other cellular processes could be assessed. However, no specific data have been reported for MEGX in cell-based assays. The compound is primarily a metabolite and is used as a marker rather than as a pharmacological agent.
ln Vivo
In in vivo animal studies, Monoethylglycinexylidide is used as a marker of liver function. The MEGX test involves the administration of lidocaine (1 mg/kg, intravenous) followed by measurement of MEGX levels in blood samples at 15-30 minutes after administration. The rate of MEGX formation reflects hepatic cytochrome P-450 activity and liver blood flow. In animal models of liver disease, MEGX formation is reduced, consistent with impaired liver function. The MEGX test is used in preclinical studies to assess liver function in rodents, dogs, and other species. Specific study protocols vary depending on the species and experimental design.
Enzyme Assay
In vitro enzyme assays for Monoethylglycinexylidide are performed using human liver microsomes or recombinant CYP enzymes (CYP3A4, CYP1A2). The assay is conducted in microcentrifuge tubes in a total volume of 200 µL. Reaction buffer consists of 100 mM potassium phosphate buffer (pH 7.4), 10 mM MgCl2, and 1 mM NADPH. Lidocaine (10-100 µM, substrate) is pre-incubated with microsomes (0.5-1 mg/mL protein) or recombinant CYP enzymes for 5 minutes at 37°C. The reaction is initiated by adding NADPH and incubated for 10-30 minutes at 37°C. The reaction is terminated by adding 50 µL of ice-cold acetonitrile containing an internal standard. Samples are centrifuged at 10,000 × g for 10 minutes, and the supernatant is analyzed for MEGX formation by HPLC with UV detection or LC-MS/MS. The amount of MEGX is quantified using a standard curve. Enzyme activity is expressed as pmol MEGX formed per mg protein per minute. Positive controls include known CYP3A4 substrates such as midazolam.
Cell Assay
For in vitro cell-based assays, primary human hepatocytes are cultured in Williams E medium with supplements at 37°C in 5% CO2. Cells are seeded in 24-well plates at 5 × 10^5 cells/well and allowed to attach for 24 hours. Lidocaine is added at concentrations of 1, 10, 50, and 100 µM, and cells are incubated for 1, 2, 4, 8, and 24 hours. Culture supernatants are collected, and MEGX levels are measured by LC-MS/MS. For cytotoxicity assessment, hepatocytes are treated with MEGX (1-100 µM) for 24 hours, and cell viability is assessed using the MTT assay. Data are expressed as MEGX concentration (µM) or as percentage of control viability.
Animal Protocol
In vivo animal studies for the MEGX test are performed in male Sprague-Dawley rats (200-250 g) or other species. Rats are anesthetized with isoflurane, and a catheter is placed in the femoral vein for drug administration and blood sampling. Lidocaine (1-2 mg/kg) is administered intravenously as a bolus. Blood samples (0.2-0.5 mL) are collected at 0, 5, 10, 15, 30, 45, and 60 minutes after lidocaine administration. Plasma is separated by centrifugation, and MEGX levels are measured by HPLC or LC-MS/MS. The MEGX concentration at 15 minutes (MEGX15) is used as the primary endpoint. In models of liver disease (e.g., CCl4-induced cirrhosis, bile duct ligation, or partial hepatectomy), MEGX formation is reduced compared to healthy controls. The MEGX test is also used in dogs and other large animal models. Data are expressed as MEGX concentration (ng/mL or µM) and compared between treatment groups.
ADME/Pharmacokinetics
Metabolism / Metabolites
Known metabolites of monoethylglycyl dimethylamine include glycyl dimethylamine and 3-hydroxymonoethylglycyl dimethylamine. Monoethylglycyl dimethylamine is a known metabolite of lidocaine.
References

[1]. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. J Hepatol. 1993 Aug;19(1):140-7.

Additional Infomation
Monoethylglycyl dimethylamine is an amino acid amide composed of 2,6-dimethylaniline and N-ethylglycine; it is the active metabolite of lidocaine, generated by oxidative deethylation. It can be used as a liver function indicator and is also a drug metabolite.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C12H18N2O
Molecular Weight
206.28
Exact Mass
206.142
CAS #
7728-40-7
Related CAS #
Monoethylglycinexylidide hydrochloride;7729-94-4;Monoethylglycinexylidide-d6;1216698-89-3;Monoethylglycinexylidide-d6 hydrochloride;2748541-96-8
PubChem CID
24415
Appearance
White to off-white solid
Density
1.047g/cm3
Boiling Point
335.6ºC at 760 mmHg
Melting Point
242-245ºC
Flash Point
127.8ºC
Index of Refraction
1.553
LogP
2.315
tPSA
41.13
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
4
Heavy Atom Count
15
Complexity
196
Defined Atom Stereocenter Count
0
SMILES
C1(=C(C=CC=C1C)C)NC(=O)CNCC
InChi Key
WRMRXPASUROZGT-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15)
Chemical Name
N-(2,6-dimethylphenyl)-2-(ethylamino)acetamide
Synonyms
L 86 L-86 L86Monoethylglycinexylidide Ethylglycylxylidide BRN 2417108
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~100 mg/mL (~484.8 mM; with ultrasonication)
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 5 mg/mL (24.24 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (50.0 mg/mL) to 400 μL of PEG300 and mix well; then add 50 μL of Tween-80 and mix well; finally add 450 μL of physiological saline and adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 5 mg/mL (24.24 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (50.0 mg/mL) to 900 μL of 20% SBE-β-CD saline and mix well.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 5 mg/mL (24.24 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (50.0 mg/mL) to 900 μL of corn oil and mix well.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.8478 mL 24.2389 mL 48.4778 mL
5 mM 0.9696 mL 4.8478 mL 9.6956 mL
10 mM 0.4848 mL 2.4239 mL 4.8478 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us